CHESS ROBERT bought NKTR
September 23, 2026 · Form 4 insider transaction
CHESS ROBERT bought 4,000 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,000
Price
$0.00
Total value
N/A
InsiderCHESS ROBERT
RoleDirector
CompanyNektar Therapeutics (NKTR)
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateSeptember 23, 2026
Filing dateSeptember 25, 2026
Shares owned after4,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option vests in substantially equal monthly installments over the one-year period beginning on September 23, 2026.